MedPharm Expands Formulation Development Labs in the UK

MedPharm Ltd, a global provider of formulation and development services for topical and transdermal products, has announced a £1.5 million refurbishment that will increase laboratory space in the UK by 30%.

The renovations will incorporate increased investment in automated technologies to maintain MedPharm’s leading edge in the pharmaceutical formulation development and testing sectors for topical and transdermal products.

Due to be completed August 2021, the increased capacity will allow MedPharm to continue meeting the demand for its topical and transdermal services.

Expanding and reimagining the laboratory space will enable a streamlined workflow which allows MedPharm’s scientists to provide optimal service to all of its clients for years to come.

“We are excited to be renovating both our laboratory and office facilities to ensure our resources remain state-of-the-art,” said Rob Turner, general manager UK, MedPharm. “MedPharm has been supporting clients from Guildford for 15 years and this renovation will secure our footprint here in Surrey for years to come.”

MedPharm has taken extensive steps to de-risk these renovations and do not expect any disruption to its services throughout the refurbishment.